drugset / Trial / NCT06991257

A Study to Learn About the Study Medicine Called PF-07328948 in Adults With Heart Failure (BRANCH-HF)

NCT06991257

Phase 2 Recruiting 620 enrolled Pfizer
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The purpose of this study is to learn about the safety and effects of the study medicine (PF-07328948) for the possible treatment of heart failure (HF).

Timeline

Start
2025-06-19
Primary completion
2027-11-16
Completion
2027-12-14

Drugs

EvaluationDrugModalityDoseRoute
Subject PF-07328948 Unknown Oral

Indications